All In Biotech

Free tool

FAERS Monitor: Onapgo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214056 or its brand name (Onapgo, Apomorphine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

1,686

Serious

1,098

65% of reports

Hospitalization

482

Death reported

102

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea316
  • somnolence279
  • dizziness225
  • dyskinesia219
  • fall204
  • hallucination164
  • fatigue158
  • hypotension150
  • injection site erythema135
  • gait disturbance114
  • injection site nodule101
  • infusion site erythema99
  • vomiting97
  • speech disorder94
  • constipation88

Reports by year received

View as table
YearReports
20041
20052
20063
20073
20102
20113
20121
20134
20148
201510
20164
201747
2018387
201924
202032
202132
202238
202346
202476
2025401
2026562

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,473 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion site erythemaSignal99148.2122.314,167
injection site noduleSignal101115.595.511,256
dyskinesiaSignal21967.659.714,250
hallucinationSignal16427.223.54,119
speech disorderSignal9422.418.41,903
somnolenceSignal27917.315.54,306
injection site erythemaSignal13513.611.61,570
hypotensionSignal1509.38.01,118
fallSignal2047.76.71,191
gait disturbanceSignal1147.46.2634
dizzinessSignal2255.65.0872
constipationSignal885.04.1283
nauseaSignal3165.04.51,041
vomitingSignal972.62.194
fatigueSignal1582.52.2150

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.